Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 13Infertility 4Leiomyoma 2Anovulation 2hCG 1Uterine Anomalies 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Ovarian Hyperstimulation Syndrome 1Infertility, Female 1Gonadal Disorders 1Endometritis 1Endometriosis 1Endocrine System Diseases 1Breast Neoplasms 1

Interventions

Triptorelin Pamoate 3ganirelix 1follicle stimulating hormone, human, with HCG C-terminal peptide 1Profasi 1Chorionic Gonadotropin 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Hyperstimulation Syndrome × Chorionic Gonadotropin × Clear all
NCT01815138 2018-10-26

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

UConn Health

Phase 4 Completed
89 enrolled 13 charts
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡